0001761302-18-000001.txt : 20181211 0001761302-18-000001.hdr.sgml : 20181211 20181211121724 ACCESSION NUMBER: 0001761302-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181211 EFFECTIVENESS DATE: 20181211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biorealize, Inc. CENTRAL INDEX KEY: 0001761302 IRS NUMBER: 810847685 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-327579 FILM NUMBER: 181228217 BUSINESS ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE, BUILDING 176 CITY: PHILADELPHIA STATE: PA ZIP: 19146 BUSINESS PHONE: 2159179660 MAIL ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE, BUILDING 176 CITY: PHILADELPHIA STATE: PA ZIP: 19146 D 1 primary_doc.xml X0708 D LIVE 0001761302 Biorealize, Inc. 3401 GRAYS FERRY AVENUE, BUILDING 176 PHILADELPHIA PA PENNSYLVANIA 19146 2159179660 DELAWARE None None Corporation true 2015 Karen Moria Hogan 930 Clyde Lane Philadelphia PA PENNSYLVANIA 19128 Executive Officer Director Promoter Orkan Telhan 20 Saint James Court Philadelphia PA PENNSYLVANIA 19106 Executive Officer Promoter Other Technology No Revenues 06b false 2018-11-26 false true true true Convertible Note false 0 249999 10000 239999 This filing covers the purchase and sale of Convertible Promissory Notes, the Preferred Stock issuable upon conversion of such Notes and the Common Stock issuable upon the conversion of such Preferred Stock. false 1 0 0 0 false Biorealize, Inc. /s/ Karen Hogan Karen Hogan Chief Executive Officer 2018-12-06